Results 181 to 190 of about 166,115 (297)

Biomarkers Predictive of Immunotherapy Efficacy in Head and Neck Squamous Cell Carcinoma: Current Insights and Future Perspectives

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT With the approval of immunotherapies by regulatory bodies, head and neck squamous cell carcinoma (HNSCC) treatment has been revolutionized, and anti‐programmed cell death‐1 (anti‐PD‐1) agents are now the standard for platinum‐resistant recurrent/metastatic HNSCC.
Xiao‐Tong Yan, Zhao‐Hong An, Chang‐Ming An   +2 more
wiley   +1 more source

Epidemiology of Incidence and Mortality Due to Head and Neck Cancer in Poland in 2000 to 2022. [PDF]

Med Sci Monit
Zaborska P, Olszewski J, Skarżyński PH.   +2 more
europepmc   +1 more source

A Further Report upon a Case of Laryngeal Neoplasm [PDF]

Proceedings of the Royal Society of Medicine, 1914
openaire   +2 more sources

Neuroendocrine Carcinoma of the Head and Neck: A Two‐Decade Institutional Experience

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Objectives Primary neuroendocrine carcinoma (NEC) of the head and neck is rare (< 1% of cases) and aggressive, with poorly defined management strategies. This study evaluated clinical characteristics, treatment patterns, and survival outcomes in a single‐institution cohort, identifying factors associated with improved survival.
Micah K. Harris, Katie M. Carlson, Nathan Lu, Anthony Tang, Matthew E. Spector, Joshua D. Smith, Jessica H. Maxwell, Kevin J. Contrera, Seungwon Kim, Steven B. Chinn, Angela Mazul, Shaum S. Sridharan   +11 more
wiley   +1 more source

Incidental detection of cancers during population-based endoscopic gastric cancer screening in Japan. [PDF]

Esophagus
Uraguchi K, Hamada K, Matsumoto N, Mitsuhashi T, Ando M, Fujimoto K, Hayase S, Yorifuji T.   +7 more
europepmc   +1 more source

Prognostic Value of FST and Relevance to Immune Infiltration in Head and Neck Squamous Cell Carcinoma

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Background Immunotherapy response rates in head and neck squamous cell carcinoma (HNSCC) are limited by multiple factors. Tumor cell‐derived follistatin (FST) has been linked to immunotherapy resistance, but the underlying mechanisms remain poorly understood. This study aimed to investigate the prognostic value of FST and its associations with
Pan Song, Tao‐Wei Wu, Jing‐Yi Wang, Yu‐Chu Ye, Fa‐ya Liang, Xiao‐Ming Huang, Ping Han   +6 more
wiley   +1 more source

Rapid Ex Vivo Visualization of Laryngeal Tumors Using a Sprayable pH-Activatable Fluorophore. [PDF]

Mol Diagn Ther
Linders DGJ, Dalmeijer SWR, Zweedijk BE, Abbasi H, Boldewijn D, Koppes SA, Kremer B, Burggraaf J, Hilling DE, van der Vorst JR, Ser J, Kashiwagi S, Henary M, Jansen JC, Vahrmeijer AL, Choi HS, Keereweer S.   +16 more
europepmc   +1 more source

Expanding the Limits of Robotic Thyroidectomy: Management of a Rare Presentation of Thyroid Carcinoma With Supraglottic Extension

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Thyroid carcinoma ranks as the seventh most common malignancy globally by incidence, though its mortality remains relatively low. We present a rare case of papillary thyroid carcinoma in a 32‐year‐old male, with supraglottic extension of the right thyroid lobe, managed successfully using a robotic‐assisted bilateral axillo‐breast approach ...
Surender Dabas, Shivya Chopra, Reetesh Ranjan, Bikas Gurung, Nandini Menon, Sukirti Tiwari, Daksh Goel, Shivani Rewari   +7 more
wiley   +1 more source

Comparative analysis of the trends in laryngeal cancer disease burden between China and the world from 1990 to 2021. [PDF]

Medicine (Baltimore)
Liao H, Wang H.
europepmc   +1 more source

Current Advances of Treatments, Therapeutic Targets, Biomarkers, Novel Drugs, and Machine Learning for Hypopharyngeal Squamous Cell Carcinoma

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Hypopharyngeal squamous cell carcinoma (HSCC) is an aggressive subtype of head and neck squamous cell carcinoma with insidious onset, early metastasis, and dismal prognosis. Conventional multimodal therapy achieves limited survival benefit, highlighting an urgent need for refined precision strategies.
Ce Li, Rui Guan, Rui‐Jie Jiao, Zhi‐Jie Bi, Yang Fu, Yin Wang, Chen‐Yang Xu, Ye Qian, Ran Wei, Sheng‐Da Cao, Wen‐Ming Li, Dong‐Min Wei, Da‐Peng Lei   +12 more
wiley   +1 more source